| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 06/04/2002 | US6399043 Radiolabeled macrocyclic gadolinium complexes with substantially better neural compatibility; enhanced signal intensity for nuclear spin tomography; water solubility and low osmolality; stable; nmr; radioimaging |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | US20020065275 To increase insulin secretion, which makes them useful for treating type II diabetes |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/29/2002 | EP1208090A1 Herbicidaltetrazolinone derivatives |
| 05/29/2002 | EP1019531A4 A method to assay enzymatic covalent bond formation and cleavage |
| 05/29/2002 | CN1351596A Tetrazoline-one derivative |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1085663C Aromatic amino ethers as pain relieving agents |
| 05/28/2002 | US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| 05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
| 05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040444A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression |
| 05/16/2002 | US20020058820 Adding ammonia water to a reaction solution containing a 5,5'-bi-1H- tetrazoledisodium salt; recovering pure 5,5'-bi-1H- tetrazolediammonium salt |
| 05/16/2002 | US20020058807 Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof |
| 05/16/2002 | US20020058653 Administering cyclic polyamine compound to elevate white blood cell (WBC) count |
| 05/16/2002 | US20020058155 Cyclic tertiary amine compound and organic electroluminescent device containing the compound |
| 05/16/2002 | DE10117242C1 New dimeric tetraazacyclododecane derivatives and their metal complexes useful as components of diagnostic agents, especially X-ray contrast agents, and radiotherapeutics |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1084743C 毒蕈碱拮抗剂 Muscarinic antagonist |
| 05/14/2002 | US6388088 Antidiabetic agents |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/10/2002 | WO2002036118A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202732A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384279 Oxidizing a diamidodiol to form a diacid followed by coupling with an aryl diamine |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052354 Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction |
| 05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 05/02/2002 | EP1201240A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | CA2358678A1 Heterocyclic derivatives useful as pharmaceutical agents |
| 04/30/2002 | CA2053478C Magnetic resonance imaging agent |
| 04/25/2002 | US20020049202 Administering halogenated amidino or oxyamidino compound to treat diseases caused by nitric oxide synthase |
| 04/25/2002 | US20020049190 Useful in binding nitric oxide; inhibiting tumor growth |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1083442C Process for prepn of tetraazaacrocycles |
| 04/23/2002 | US6376655 Physically functional materials |
| 04/23/2002 | US6376532 Neurotransmitter |
| 04/23/2002 | US6376484 For prevention and/or treatment of various kinds of inflammatory disease |
| 04/23/2002 | CA2032261C Antiviral polyheterocyclic dimers |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | US20020045664 Estrogen mimetics lacking reproductive tract effects |
| 04/18/2002 | DE10047794A1 New RNA-cleaving polyaza-cycloalkane complex, useful e.g. in medical genetics, preferentially cleaves after an unpaired uridine |
| 04/18/2002 | DE10046934A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren A process for the fermentative production of non-proteinogenic L-amino acids |
| 04/18/2002 | CA2425678A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425674A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
| 04/17/2002 | CN1344801A Method for production of non-proteinogen L-amino acid by fermentation |
| 04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/10/2002 | CN1344262A Perfuoroalkylamide, prodn. thereof and use thereof in diagnostics |
| 04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/10/2002 | CN1082508C antivirally active heterocyclic azahexane derivatives |
| 04/09/2002 | US6369232 Antidiabetic agents |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/04/2002 | WO2002026721A1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof |
| 04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
| 04/04/2002 | US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 04/04/2002 | US20020039767 Batch processing using nucleophilic compound |
| 04/04/2002 | CA2419631A1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof |
| 04/03/2002 | EP1193250A1 Phenyl sulfamate derivatives |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | CN1343203A Process for preparation of 1,4,7,10-tetraazacyclododecane |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 03/28/2002 | WO2002024630A1 Pharmaceutical compounds useful as modulators of endocannabinoid-mediated response |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2002009651A3 Fatty acid synthase inhibitors |
| 03/28/2002 | US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/27/2002 | EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren |
| 03/27/2002 | EP1189873A1 Excitatory amino acid receptor modulators |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362212 Oxime derivative and bactericide containing the same as active ingredient |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/21/2002 | WO2002022627A2 Ligands for metabotropic glutamate receptors |
| 03/21/2002 | WO2002022584A1 Thrombin inhibitors |
| 03/21/2002 | WO2002022581A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | US20020035267 Tetrazolyl-phenyl acetamide glucokinase activators |